Literature DB >> 6220750

Severe deficiency of natural killer activity in the peripheral blood of patients with hairy cell leukemia.

L P Ruco, A Procopio, V Maccallini, A Calogero, S Uccini, L Annino, F Mandelli, C D Baroni.   

Abstract

Natural killer (NK) activity against K-562 tumor cells was evaluated in peripheral blood leukocytes (PBL) obtained from untreated patients affected by hairy cell leukemia (HCL). NK activity present in PBL from 10 HCL patients was at least six-fold lower (p less than 0.01) than that present in PBL from 15 healthy donors. Decreased NK activity in HCL PBL was not due to dilution of the NK effector cells by the neoplastic cells; in fact, NK activity of PBL from 4 HCL patients with less than 5% circulating neoplastic cells was still five-fold lower (p less than 0.01) than that present in normal PBL. Partial characterization of the NK defect in HCL patients indicated that: (A) defective cytotoxicity was not dependent on the duration of the assay; (B) HCL PBL added to normal PBL during the assay did not exert suppressor activity; (C) the NK activity of HCL PBL could be potentiated in vitro by interferon; and (D) low levels of NK activity were associated with reduced numbers of circulating monocytes (p less than 0.01) and of large granular lymphocytes (LGL) (p less than 0.01). In conclusion, our results indicate that the low levels of NK activity present in the peripheral blood of HCL patients may be related to reduced numbers of circulating effector cells.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6220750

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  12 in total

Review 1.  Hairy cell leukemia: clinical features and therapeutic advances.

Authors:  B C Lembersky; H M Golomb
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

2.  Primary treatment of hairy cell leukemia: should IFN-therapy replace splenectomy?

Authors:  F Porzsolt
Journal:  Blut       Date:  1986-05

3.  Alpha-interferon induces remission in hairy cell leukemia without enhancement of natural killing.

Authors:  G Gastl; W Aulitzky; E Leiter; R Flener; C Huber
Journal:  Blut       Date:  1986-05

Review 4.  The optimal management of hairy cell leukaemia.

Authors:  R Gollard; T C Lee; L D Piro; A Saven
Journal:  Drugs       Date:  1995-06       Impact factor: 9.546

5.  Loss of natural killer activity as an indicator of relapse in acute leukaemia.

Authors:  J A Tratkiewicz; J Szer
Journal:  Clin Exp Immunol       Date:  1990-05       Impact factor: 4.330

6.  Decreased NK activity in hairy cell leukemia (HCL): an analysis at the cellular level.

Authors:  L Fontana; G De Rossi; G De Sanctis; F Ensoli; M Lopez; L Annino; F Mandelli
Journal:  Blut       Date:  1986-08

7.  Incidental Detection of Hairy Cell Leukaemia with Herpes Simplex Virus (HSV) Related Lip Ulcer Mimicking Carcinoma.

Authors:  Pallavi Agrawal; Richa Bhartiya; Ran Vijoy Narayan Singh
Journal:  J Clin Diagn Res       Date:  2016-08-01

8.  Phenotypic and functional characterization of the circulating NK compartment in hairy cell leukaemia.

Authors:  R Foa; F Lauria; P Lusso; D Raspadori; M T Fierro; P L Tazzari; L Caudana; L Matera
Journal:  Clin Exp Immunol       Date:  1986-05       Impact factor: 4.330

9.  Lymphocytes from patients with hairy cell leukaemia enable the distinction of two separate subpopulations of activated lymphocyte killer cells generated in mixed lymphocyte culture.

Authors:  J A Werkmeister; A W Boyd; T Triglia; G F Burns
Journal:  Clin Exp Immunol       Date:  1985-07       Impact factor: 4.330

10.  Natural-killer-stimulatory effect of combined low-dose interleukin-2 and interferon beta in hairy-cell leukemia patients.

Authors:  A M Liberati; V De Angelis; M Fizzotti; M Schippa; M Cecchini; D Adiuto; F Di Clemente; L Palmisano; E Micozzi; M Zuccaccia
Journal:  Cancer Immunol Immunother       Date:  1994-05       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.